Altitude sickness drug may tame immune overreaction
NCT ID NCT07517068
First seen Apr 08, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study looks at whether the drug acetazolamide, commonly used to prevent altitude sickness, can also reduce inflammation and immune system activation caused by high altitude. Nineteen healthy adults will take either the drug or a placebo during a short stay at high elevation. The goal is to understand how the drug affects immune cells and inflammatory markers, not to treat a disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOXEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, Riverside
Riverside, California, 92521, United States
Conditions
Explore the condition pages connected to this study.